PDB22 SELF-MONITORING OF BLOOD GLUCOSE (SMBG) FOR TYPE 2 DIABETES PATIENTS ON ORAL ANTI-DIABETES DRUGS (OADS)- COST-EFFECTIVENESS IN FRANCE, GERMANY, AND SPAIN
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)75000-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)75000-2/fulltext
Title :
PDB22 SELF-MONITORING OF BLOOD GLUCOSE (SMBG) FOR TYPE 2 DIABETES PATIENTS ON ORAL ANTI-DIABETES DRUGS (OADS)- COST-EFFECTIVENESS IN FRANCE, GERMANY, AND SPAIN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)75000-2&doi=10.1016/S1098-3015(10)75000-2
First page :
Section Title :
Open access? :
No
Section Order :
924